CBT-I: Cognitive behavioral therapy for insomnia; FDA: Food and drug administration; MBSR: Mindfulness-based stress reduction; MVP: Mindfulness versus pharmacotherapy for chronic insomnia trial; RCT: Randomized controlled trial; US: United States of America.
The Moxifloxacin in Acute Exacerbations of Chronic Bronchitis TriaL (MAESTRAL) was a multiregional, randomised, double-blind non-inferiority outpatient study.
The Diabetes Chronic Complications Trial (DCCT) and its ancillary study, Epidemiology of Diabetes Interventions and Complications (EDIC), with ten years of intervention and an additional ten years of observation demonstrated that microalbuminuria could regress.
Patients were allowed to transition between SAQAF states (first cycle only) or death (any cycle) based on probabilities derived from the randomised, controlled Efficacy of Ranolazine in Chronic Angina trial and other studies.
The initiative on methods, measurement, and pain assessment in clinical trials defined the following outcome domains as important for chronic pain trials: pain, physical functioning, emotional functioning, participants' ratings of improvement and satisfaction, symptoms and adverse events, and participants' disposition.
Therefore, an Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials consensus meeting was convened in which the assay sensitivity of chronic pain trials was reviewed and discussed.
We defined a 'catalytic' fructose intake in chronic feeding trials as ≤ 36 g/d based on doses of ≤ 10 g/bolus in acute trials, allowing for three meals (10 g/meal) and two snacks (3 g/snack) per d.
Fifteen percent of acute LBP trials had a positive outcome, compared to 86% and 74% of subacute and chronic LBP trials respectively.
Notably, a range of potential biases hinders the interpretation of chronic pain trials.
According to the guidelines of the IHS, an intervention is recommended to last at least 3 months in chronic migraine trials [33].
